• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    More On CNJ.TO

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Cangene Corp. (CNJ.TO)

    -Toronto
    0.00 0.00(0.00%) N/A
    Add to Portfolio
    Prev Close:N/A
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:2.05 - 3.61
    Volume:0
    Avg Vol (3m):255,197
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.15
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in .

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jul-14) :N/A
    Quarterly EPS Est (Jan-14) :N/A
    Mean Recommendation*:4.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cangene Corporation, a biopharmaceutical company, develops, manufactures, and commercializes immune therapeutics in North America and internationally. The company operates in two segments, Biopharmaceutical Operations and Contract Services. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback